Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

Among pediatric and adult patients with cystic fibrosis, the average number of chronic respiratory therapies used fell after ...

Please provide your email address to receive an email when new articles are posted on . Few patients with cystic fibrosis have a copy of the 3849+10kb C-to-T splicing mutation. Research is planned to ...

Cystic fibrosis (CF) and pulmonary fibrosis (PF) are two chronic conditions that damage the lungs. Treatment for both aims to improve breathing, manage symptoms, and prevent further lung damage. Your ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has approved ...

While gene therapy for cystic fibrosis is still in the research phase, researchers aim to correct the defective gene responsible for the disease. Current research is promising. Cystic fibrosis (CF) is ...

If approved, gene therapies could fill gaps in patient care left by CFTR modulators, notes GD Healthcare analyst, Vinie Varkey.

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

MARSHFIELD, Wis. (WSAW) - A Rhinelander family is navigating treatment, and learning what their son’s future looks like after his Cystic Fibrosis diagnosis. Cystic Fibrosis, or CF, is a genetic ...

FILE PHOTO: A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston (Reuters) - Vertex Pharmaceuticals missed Wall Street estimates for third-quarter sales on Monday, hurt ...